State Street’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $155M | Buy |
|
|||||
|
2025
Q2 | $133M | Sell |
|
|||||
|
2025
Q1 | $116M | Buy |
|
|||||
|
2024
Q4 | $83M | Sell |
|
|||||
|
2024
Q3 | $91.9M | Buy |
|
|||||
|
2024
Q2 | $94.3M | Sell |
|
|||||
|
2024
Q1 | $111M | Sell |
|
|||||
|
2023
Q4 | $202M | Buy |
|
|||||
|
2023
Q3 | $109M | Sell |
|
|||||
|
2023
Q2 | $130M | Sell |
|
|||||
|
2023
Q1 | $105M | Sell |
|
|||||
|
2022
Q4 | $123M | Buy |
|
|||||
|
2022
Q3 | $111M | Buy |
|
|||||
|
2022
Q2 | $92.9M | Buy |
|
|||||
|
2022
Q1 | $122M | Buy |
|
|||||
|
2021
Q4 | $112M | Sell |
|
|||||
|
2021
Q3 | $95.1M | Buy |
|
|||||
|
2021
Q2 | $96.8M | Buy |
|
|||||
|
2021
Q1 | $82.8M | Buy |
|
|||||
|
2020
Q4 | $140M | Sell |
|
|||||
|
2020
Q3 | $111M | Buy |
|
|||||
|
2020
Q2 | $124M | Sell |
|
|||||
|
2020
Q1 | $171M | Buy |
|
|||||
|
2019
Q4 | $171M | Buy |
|
|||||
|
2019
Q3 | $124M | Sell |
|
|||||
|
2019
Q2 | $124M | Sell |
|
|||||
|
2019
Q1 | $131M | Buy |
|
|||||
|
2018
Q4 | $78.3M | Sell |
|
|||||
|
2018
Q3 | $142M | Buy |
|
|||||
|
2018
Q2 | $89M | Buy |
|
|||||
|
2018
Q1 | $93.8M | Buy |
|
|||||
|
2017
Q4 | $100M | Buy |
|
|||||
|
2017
Q3 | $122M | Sell |
|
|||||
|
2017
Q2 | $105M | Buy |
|
|||||
|
2017
Q1 | $111M | Sell |
|
|||||
|
2016
Q4 | $96.7M | Buy |
|
|||||
|
2016
Q3 | $98.9M | Buy |
|
|||||
|
2016
Q2 | $73.9M | Sell |
|
|||||
|
2016
Q1 | $94.1M | Buy |
|
|||||
|
2015
Q4 | $84.4M | Buy |
|
|||||
|
2015
Q3 | $65.7M | Buy |
|
|||||
|
2015
Q2 | $80.6M | Sell |
|
|||||
|
2015
Q1 | $62.9M | Buy |
|
|||||
|
2014
Q4 | $56.8M | Sell |
|
|||||
|
2014
Q3 | $46.7M | Sell |
|
|||||
|
2014
Q2 | $45M | Sell |
|
|||||
|
2014
Q1 | $49.3M | Buy |
|
|||||
|
2013
Q4 | $48.3M | Sell |
|
|||||
|
2013
Q3 | $57.9M | Buy |
|
|||||
|
2013
Q2 | $35.7M | Buy |
|